Reply to the letter to the editor 'second-line chemotherapy in advanced biliary cancer: the present now will later be past' by Vivaldi et al

Ann Oncol. 2014 Dec;25(12):2444-2445. doi: 10.1093/annonc/mdu382. Epub 2014 Aug 19.

Authors

A Lamarca¹, R A Hubner¹, W D Ryder², J W Valle³

Affiliations

¹ Department of Medical Oncology, Academic Health Sciences Centre, Manchester.
² MAHSC Clinical Trials Unit, The Christie NHS Foundation Trust, Manchester, UK.
³ Department of Medical Oncology, Academic Health Sciences Centre, Manchester. Electronic address: juan.valle@christie.nhs.uk.

PMID: 25139549
DOI: 10.1093/annonc/mdu382

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Agents / therapeutic use*
Biliary Tract Neoplasms / drug therapy*
Humans

Substances

Antineoplastic Agents

Grants and funding

16281/CRUK_/Cancer Research UK/United Kingdom